Pre-Transplant Rituximab Is Associated with a Greatly Reduced Risk of Epstein-Barr Virus Reactivation Following Allogeneic Stem Cell Transplantation

被引：0
|
作者：
Burns, David [1 ]
Rana, Shabeeha [2 ]
Howman, Andrew [3 ]
Nagra, Sandeep [1 ]
Ward, Janice [1 ]
Osman, Husam [4 ]
Taha, Yusri [5 ,6 ]
Byrne, Jenny [2 ]
Das-Gupta, Emma [2 ]
Raghavan, Manoj [1 ]
Malladi, Ram [1 ]
Cook, Mark [1 ]
Mahendra, Prem [1 ]
Russell, Nigel H. [2 ]
Craddock, Charles [1 ]
Fox, Christopher [2 ]
Chaganti, Sridhar [1 ]
机构：
[1] Univ Hosp Birmingham NHS Trust, Ctr Clin Haematol, Birmingham, W Midlands, England
[2] Nottingham Univ Hosp NHS Trust, Ctr Clin Haematol, Nottingham, England
[3] Univ Birmingham, Canc Res UK Clin Trials Unit, Birmingham, W Midlands, England
[4] Birmingham Heartlands Hosp, Hlth Protect Agcy Lab, Birmingham B9 5ST, W Midlands, England
[5] Nottingham Univ Hosp NHS Trust, Dept Virol, Nottingham, England
[6] Nottingham Univ Hosp NHS Trust, Dept Infect Dis, Nottingham, England
来源：
BLOOD | 2012年 / 120卷 / 21期
关键词：
D O I：
10.1182/blood.V120.21.460.460
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
460
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Controlled Epstein-Barr virus reactivation after allogeneic transplantation is associated with improved survival
    Auger, Sophie
    Orsini, Mattea
    Ceballos, Patrice
    Fegueux, Nathalie
    Kanouni, Tarik
    Caumes, Bastien
    Klein, Bernard
    Villalba, Martin
    Rossi, Jean-Francois
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2014, 92 (05) : 421 - 428
  • [22] Epstein–Barr virus reactivation after allogeneic hematopoietic stem cell transplantation: multifactorial impact on transplant outcomes
    Yuhua Ru
    Xiang Zhang
    Tiemei Song
    Yiyang Ding
    Ziling Zhu
    Yi Fan
    Yang Xu
    Aining Sun
    Huiying Qiu
    Zhengming Jin
    Xiaowen Tang
    Yue Han
    Zhengzheng Fu
    Suning Chen
    Xiao Ma
    Feng Chen
    Jia Chen
    Depei Wu
    Bone Marrow Transplantation, 2020, 55 : 1754 - 1762
  • [23] Increased Infection Rate After Preemptive Rituximab Treatment for Epstein-Barr Virus Reactivation After Allogeneic Hematopoietic Stem-Cell Transplantation
    Petropoulou, Anna D.
    Porcher, Raphael
    de Latour, Regis Peffault
    Xhaard, Alienor
    Weisdorf, Daniel
    Ribaud, Patricia
    Rodriguez-Otero, Paula
    Agbalika, Felix
    Talbot, Alexis
    Toubert, Antoine
    Moins-Teisserenc, Helene
    Carmagnat, Maryvonnick
    Socie, Gerard
    Robin, Marie
    TRANSPLANTATION, 2012, 94 (08) : 879 - 883
  • [24] SPECTRUM OF EPSTEIN-BARR VIRUS-ASSOCIATED DISEASES IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Xuan, L.
    Jiang, X.
    Sun, J.
    Zhang, Y.
    Huang, F.
    Fan, Z.
    Guo, X.
    Dai, M.
    Liu, C.
    Yu, G.
    Zhang, X.
    Wu, M.
    Liu, Q.
    HAEMATOLOGICA, 2013, 98 : 148 - 149
  • [25] Active Epstein-Barr virus infection after allogeneic stem cell transplantation: re-infection or reactivation?
    Meijer, E
    Spijkers, S
    Moschatsis, S
    Boland, GJ
    Thijsen, SFT
    van Loon, AM
    Verdonck, LF
    TRANSPLANT INFECTIOUS DISEASE, 2005, 7 (01) : 4 - 10
  • [26] Characteristics of Epstein–Barr virus reactivation after allogeneic haematopoietic stem cell transplantation in patients with chronic active Epstein–Barr virus disease: favorable responses to rituximab
    Na Wei
    Yini Wang
    Jingshi Wang
    Lin Wu
    Zhao Wang
    Bone Marrow Transplantation, 2021, 56 : 1449 - 1451
  • [27] Incidence, risk factors, and clinical significance of Epstein-Barr virus reactivation in myelodysplastic syndrome after allogeneic haematopoietic stem cell transplantation
    Wang, Hong
    Zhang, Tong-Tong
    Qi, Jia-Qian
    Chu, Tian-Tian
    Miao, Miao
    Qiu, Hui-Ying
    Fu, Cheng-Cheng
    Tang, Xiao-Wen
    Ruan, Chang-Geng
    Wu, De-Pei
    Han, Yue
    ANNALS OF HEMATOLOGY, 2019, 98 (04) : 987 - 996
  • [28] Increased Epstein-Barr virus reactivation but similar incidence of post-transplant lymphoproliferative disorders due to pre-emptive rituximab therapy following allogeneic hematopoietic stem cell transplantation in the letermovir era for cytomegalovirus prophylaxis
    Zhen, Sisi
    Liu, Li
    Zhang, Xiaoyu
    Wang, Jieru
    Sun, Jiali
    Liang, Chen
    Cao, Wenbin
    Wei, Jialin
    Zhai, Weihua
    Chen, Xin
    Ma, Qiaoling
    Zhang, Rongli
    Yang, Donglin
    He, Yi
    Pang, Aiming
    Han, Mingzhe
    Jiang, Erlie
    Feng, Sizhou
    BONE MARROW TRANSPLANTATION, 2025,
  • [29] Epstein-Barr virus reactivation in allogeneic stem cell transplantation: Relationship between viral load, EBV-specific T cell reconstitution and rituximab therapy
    Clave, E
    Agbalika, F
    Bajzik, V
    Socie, G
    Gluckman, E
    Charron, D
    Esperou, H
    Toubert, A
    Moins-Teisserenc, H
    GENES AND IMMUNITY, 2004, 5 : S5 - S5
  • [30] Weekly Low-Dose Rituximab As the Preemptive Management of Epstein-Barr Virus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation: A Novel Strategy?
    Chen, Feng
    Depei, Wu
    Tao, Tao
    Gong, Wei
    Ye, Chunmei
    Tang, XiaoWen
    Han, Yue
    Qiu, Huiying
    BLOOD, 2015, 126 (23)
12345